Todd Creech

Todd Creech

Chief Financial Advisor

Todd Creech is a Partner with HealthQuest Capital, and has spent the last nine years as a healthcare CFO, helping build several successful companies to profitable exits. He currently serves as board member of HealthQuest portfolio companies Alcresta, BioIQ and Etairos and an observer for HealthChannels, Springbuk, and Venus Concept. He previously served as an observer for InMediata and Avedro (acquired by Glaukos). Previously, he served as CFO for ZS Pharma, Sarcode and Sirion Therapeutics. During his CFO tenure he has raised more than $500M in equity and debt, helping to build operations and companies that generated over $3.5B in exits. Earlier in his career, Mr. Creech did healthcare venture investing for Quintiles and worked with SRI International. He has also co-founded two companies; a spectroscopy platform spinout of Duke University (Centice) and a specialty pharmaceutical company (TLC Pharma). Mr. Creech holds BA in Finance and Accounting from Miami (Ohio) University and an MBA from Duke University.